Macular Degeneration Treatment Market to Witness Massive Growth (2024-2031) | Novartis AG, Regeneron Pharmaceuticals Inc., Genentech USA, Inc.

The Global Macular Degeneration Treatment Market reached USD 9.3 billion in 2022 and is projected to witness lucrative growth by reaching up to USD 15.3 billion by 2031. The global macular degeneration treatment market is expected to exhibit a CAGR of 6.6% during the forecast period (2024-2031)

Macular Degeneration Treatment Market report, published by DataM Intelligence, provides in-depth insights and analysis on key market trends, growth opportunities, and emerging challenges. Committed to delivering actionable intelligence, DataM Intelligence empowers businesses to make informed decisions and stay ahead of the competition. Through a combination of qualitative and quantitative research methods, it offers comprehensive reports that help clients navigate complex market landscapes, drive strategic growth, and seize new opportunities in an ever-evolving global market.

Get a Free Sample PDF Of This Report (Get Higher Priority for Corporate Email ID):- https://datamintelligence.com/download-sample/macular-degeneration-treatment-market?rk

Macular degeneration treatment aims to slow the progression of age-related macular degeneration (AMD), a leading cause of vision loss. Anti-VEGF injections (e.g., ranibizumab, aflibercept) are commonly used for wet AMD to reduce abnormal blood vessel growth. Other options include laser therapy, photodynamic therapy, and nutritional supplements (AREDS formula). Early detection and lifestyle changes, such as smoking cessation and a healthy diet, can help prevent further deterioration. Advanced treatments, including gene therapy, are being explored for long-term vision preservation.

List of the Key Players in the Macular Degeneration Treatment Market:

Novartis AG, Regeneron Pharmaceuticals Inc., Genentech USA, Inc., REGENXBIO Inc., Bausch Health Companies Inc., F Hoffmann-La Roche Ltd, Santen Pharmaceutical Co., Ltd., GNH Pharmaceuticals USA LLC, Iveric Bio Inc., and Allergan, Inc.

Industry Development:

❁ On April 21, 2023, Janssen Pharmaceutical Companies of Johnson & Johnson announced that five of its company-sponsored presentations would be featured at the Association for Research in Vision and Ophthalmology (ARVO) 2023 Annual Meeting in New Orleans, held from April 23-27, 2023. Janssen's presentations will include updates from the Phase 1/2 MGT009 trial of the investigational gene therapy botaretigene sparoparvovec (bota-vec, formerly AAV-RPGR) for patients with X-linked retinitis pigmentosa (XLRP), an inherited retinal disease associated with the RPGR gene. Additionally, pooled safety data from two Phase 1 trials of JNJ-81201887, an investigational gene therapy, will be presented. These trials include one in patients with geographic atrophy (GA), a severe form of age-related macular degeneration (AMD), and another in patients with wet AMD.

For Direct Purchase: https://datamintelligence.com/buy-now-page?report=macular-degeneration-treatment-market?rk

Growth Forecast Projected:

The Global Macular Degeneration Treatment Market is anticipated to rise at a considerable rate during the forecast period, between 2024 and 2031. In 2023, the market is growing at a steady rate, and with the rising adoption of strategies by key players, the market is expected to rise over the projected horizon.

Research Process:

Both primary and secondary data sources have been used in the global Macular Degeneration Treatment Market research report. During the research process, a wide range of industry-affecting factors are examined, including governmental regulations, market conditions, competitive levels, historical data, market situation, technological advancements, upcoming developments, in related businesses, as well as market volatility, prospects, potential barriers, and challenges.

Make an Enquiry for purchasing this Report @ https://www.datamintelligence.com/enquiry/macular-degeneration-treatment-market?rk

Segment Covered in the Macular Degeneration Treatment Market:

By Type: Wet Macular Degeneration, Dry Macular Degeneration

By Treatment: Drugs, Therapy, Surgery, Others

By End-User: Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, Others

By Distribution Channel: Hospital Pharmacies, Retail Pharmacies, Online Pharmacies

Regional Analysis for Macular Degeneration Treatment Market:

The regional analysis of the Macular Degeneration Treatment Market covers key regions including North America, Europe, Asia Pacific Middle East and Africa and South America. The North America with a focus on the U.S., Canada, and Mexico; Europe, highlighting major countries like the U.K., Germany, France, and Italy, along with other nations in the region; Asia-Pacific, covering India, China, Japan, South Korea, and Australia, among others; South America, with emphasis on Colombia, Brazil, and Argentina; and the Middle East & Africa, which includes Saudi Arabia, the U.A.E., South Africa, and other countries. This comprehensive regional breakdown helps identify unique market trends and growth opportunities specific to each area.

⇥ North America (U.S., Canada, Mexico)

⇥ Europe (U.K., Italy, Germany, Russia, France, Spain, The Netherlands and Rest of Europe)

⇥ Asia-Pacific (India, Japan, China, South Korea, Australia, Indonesia Rest of Asia Pacific)

⇥ South America (Colombia, Brazil, Argentina, Rest of South America)

⇥ Middle East & Africa (Saudi Arabia, U.A.E., South Africa, Rest of Middle East & Africa)

Benefits of the Report:

➡ A descriptive analysis of demand-supply gap, market size estimation, SWOT analysis, PESTEL Analysis and forecast in the global market.

➡ Top-down and bottom-up approach for regional analysis

➡ Porter's five forces model gives an in-depth analysis of buyers and suppliers, threats of new entrants & substitutes and competition amongst the key market players.

➡ By understanding the value chain analysis, the stakeholders can get a clear and detailed picture of this Market

Speak to Our Analyst and Get Customization in the report as per your requirements: https://datamintelligence.com/customize/macular-degeneration-treatment-market?rk

People Also Ask:

➠ What is the global sales, production, consumption, import, and export value of the Macular Degeneration Treatment market?

➠ Who are the leading manufacturers in the global Macular Degeneration Treatment industry? What is their operational status in terms of capacity, production, sales, pricing, costs, gross margin, and revenue?

➠ What opportunities and challenges do vendors in the global Macular Degeneration Treatment industry face?

➠ Which applications, end-users, or product types are expected to see growth? What is the market share for each type and application?

➠ What are the key factors and limitations affecting the growth of the Macular Degeneration Treatment market?

➠ What are the various sales, marketing, and distribution channels in the global industry?

Browse More Reports: https://www.datamintelligence.com/research-report/macular-degeneration-treatment-market

Contact Us -

Company Name: DataM Intelligence
Contact Person: Sai Kiran
Email: Sai.k@datamintelligence.com
Phone: +1 877 441 4866
Website: https://www.datamintelligence.com

About Us -

DataM Intelligence is a Market Research and Consulting firm that provides end-to-end business solutions to organizations from Research to Consulting. We, at DataM Intelligence, leverage our top trademark trends, insights and developments to emancipate swift and astute solutions to clients like you. We encompass a multitude of syndicate reports and customized reports with a robust methodology.

Our research database features countless statistics and in-depth analyses across a wide range of 6300+ reports in 40+ domains creating business solutions for more than 200+ companies across 50+ countries; catering to the key business research needs that influence the growth trajectory of our vast clientele.

This release was published on openPR.